Pharmsville

318010 · KOSDAQ · ₩318010 · 팜스빌

₩3,390▲ ₩45 (1.35%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩2.4B₩2.5B₩3B₩3.4B₩3.1B₩3.3B₩3.6B₩4.2B
Cost of sales₩814M₩857M₩1.2B₩1.2B₩1.1B₩1.2B₩1.3B₩1.6B
Gross profit₩1.6B₩1.6B₩1.7B₩2.2B₩1.9B₩2.2B₩2.3B₩2.6B
Operating income−₩162M−₩55M−₩351M−₩119M−₩292M₩89M−₩184M−₩213M
Net income₩475M₩1.2B₩831M₩500M₩466M₩1.1B₩950M₩245M
Net income to shareholders₩466M₩1.2B₩824M₩494M₩466M₩1.1B₩949M₩245M

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩68B₩69B₩69B₩69B₩68B₩68B₩67B₩69B
Current assets₩38B₩42B₩41B₩42B₩40B₩41B₩41B₩43B
Cash and equivalents₩4.9B₩6.5B₩1.7B₩2.6B₩2.3B₩2.8B₩18B₩5.3B
Total liabilities₩1.7B₩1.6B₩2B₩2.6B₩2.3B₩2.9B₩2.5B₩5.8B
Current liabilities₩1.6B₩1.5B₩1.9B₩2.2B₩2B₩2.5B₩2.2B₩3.8B
Borrowings₩9.4M——₩0———₩545M
Total equity₩67B₩68B₩67B₩66B₩65B₩65B₩65B₩64B
Shareholders' equity₩67B₩68B₩66B₩66B₩65B₩65B₩65B₩64B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.1B−₩7.3M₩210M₩272M₩1B₩367M−₩1.6B−₩176M
Capital spending——₩0₩0——₩5M₩6.5M
Free cash flow₩1.1B−₩7.3M₩210M₩272M₩1B₩367M−₩1.6B−₩182M
Dividends paid——₩1.5B−₩1.5B₩0₩773M₩0₩0

Consolidated where available. Amounts in won.

Also known as: Pharmsville / 팜스빌 / 318010 / KRX:318010

Source: KRX statistical information